Figure 4

ROC curves plotted to calculate sensitivity, specificity, PPV and NPV. (A) CDH5:HPA ratio for all patients (solid line) and for vascular invasion positive, ER-positive patients (broken line). (B) Comparison of CA15.3, CEA and CDH:HPA.